GAMC
BMY icon

Garner Asset Management Corp’s Bristol-Myers Squibb BMY Stock Holding History

Garner Asset Management Corp’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-640
Closed -$34.5K – 178
2025
Q4 		$34.5K Buy
+640
New +$30.8K 0.01% 261
2024
Q1 		– Sell
-878
Closed -$42.3K – 172
2023
Q4 		$42.3K Buy
+878
New +$46.1K 0.02% 199

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Garner Asset Management Corp's BMY Position: Q1 2026 in Review

Garner Asset Management Corp sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 640 shares — an estimated $34.5K sold.

Garner Asset Management Corp first reported a position in BMY in Q4 2023 and held it in 2 quarters. The position peaked at $42.3K in Q4 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Garner Asset Management Corp reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Garner Asset Management Corp sold 640 Bristol-Myers Squibb shares in Q1 2026, an estimated $34.5K.
  • Garner Asset Management Corp first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 2 quarters.
  • Garner Asset Management Corp's Bristol-Myers Squibb position peaked at $42.3K in Q4 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Garner Asset Management Corp's 13F filing for Q1 2026, filed 29 Apr 2026.